“When loss of response to a first TNFi [TNF inhibitor] necessitates escalation, class switching appears to confer a clinically meaningful 3.9% absolute risk reduction in incident IMID over 5 years,” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback